Johnson & Johnson CEO to step down in April (AP)

Your Health Matters

In this undated photo provided by Johnson & Johnson, Alex Gorsky is shown. Johnson & Johnson's longtime CEO, Bill Weldon, is retiring in April, following an embarrassing string of product recalls over more than two years that has cost the health care giant hundreds of millions of dollars and consumer trust. The maker of Band-Aids and biotech drugs said Tuesday that Weldon will remain chairman of the board for the time being, while ceding the chief executive post to Alex Gorsky, head of the medical device and diagnostics business. (AP Photo/Johnson & Johnson)AP – Johnson & Johnson’s longtime CEO Bill Weldon is stepping down as the health care giant’s top executive after an embarrassing string of recalls of everything from Tylenol to Benadryl that has cost the company hundreds of millions of dollars and consumers’ trust.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave